Therapeutic drug monitoring of pazopanib: Using cost-neutral PK-guided interventions to optimize exposure.

Groenland, SL; van Eerden, RAG; Koolen, SLW; Moes, DJAR; Imholz, A; Wilgenhof, S; Van Der Graaf, WTA; Gelderblom, H; Beijnen, JH; Mathijssen, RHJ; Huitema, A; Steeghs, N

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索